254 related articles for article (PubMed ID: 16086941)
1. Inflammatory response after intervention assessed by serial C-reactive protein measurements correlates with restenosis in patients treated with coronary stenting.
Dibra A; Mehilli J; Braun S; Hadamitzky M; Baum H; Dirschinger J; Schühlen H; Schömig A; Kastrati A
Am Heart J; 2005 Aug; 150(2):344-50. PubMed ID: 16086941
[TBL] [Abstract][Full Text] [Related]
2. Serum C-reactive protein response to percutaneous coronary intervention in patients with unstable or stable angina pectoris is associated with the risk of clinical restenosis.
Saleh N; Tornvall P
Atherosclerosis; 2007 Dec; 195(2):374-8. PubMed ID: 17126343
[TBL] [Abstract][Full Text] [Related]
3. Enhanced inflammatory response to coronary stenting marks the development of clinically relevant restenosis.
Caixeta AM; Brito FS; Costa MA; Serrano CV; Petriz JL; Da Luz PL
Catheter Cardiovasc Interv; 2007 Mar; 69(4):500-7. PubMed ID: 17285569
[TBL] [Abstract][Full Text] [Related]
4. Pre-procedural plasma levels of C-reactive protein and interleukin-6 do not predict late coronary angiographic restenosis after elective stenting.
Segev A; Kassam S; Buller CE; Lau HK; Sparkes JD; Connelly PW; Seidelin PH; Natarajan MK; Cohen EA; Strauss BH
Eur Heart J; 2004 Jun; 25(12):1029-35. PubMed ID: 15191773
[TBL] [Abstract][Full Text] [Related]
5. Prognostic impact of preprocedural C reactive protein levels on 6-month angiographic and 1-year clinical outcomes after drug-eluting stent implantation.
Park DW; Lee CW; Yun SC; Kim YH; Hong MK; Kim JJ; Park SW; Park SJ
Heart; 2007 Sep; 93(9):1087-92. PubMed ID: 17309906
[TBL] [Abstract][Full Text] [Related]
6. Parameters of the tissue factor pathway with coumadin/dipyridamole versus ticlopidine as adjunct antithrombotic-drug regimen in coronary artery stenting.
Kopp CW; Steiner S; Priglinger U; Christ G; Probst P; Maurer G; Minar E; Huber K
Blood Coagul Fibrinolysis; 2003 Jun; 14(4):379-86. PubMed ID: 12945880
[TBL] [Abstract][Full Text] [Related]
7. Percutaneous coronary intervention triggers a systemic inflammatory response in patients treated for in-stent restenosis -- comparison with stable and unstable angina.
Kozinski M; Krzewina-Kowalska A; Kubica J; Zbikowska-Gotz M; Dymek G; Piasecki R; Sukiennik A; Grzesk G; Bogdan M; Chojnicki M; Dziedziczko A; Sypniewska G
Inflamm Res; 2005 May; 54(5):187-93. PubMed ID: 15953990
[TBL] [Abstract][Full Text] [Related]
8. Preprocedural inflammatory markers do not predict restenosis after successful coronary stenting.
Gomma AH; Hirschfield GM; Gallimore JR; Lowe GD; Pepys MB; Fox KM
Am Heart J; 2004 Jun; 147(6):1071-7. PubMed ID: 15199358
[TBL] [Abstract][Full Text] [Related]
9. Comparison of C-reactive protein levels before and after coronary stenting and restenosis among patients treated with sirolimus-eluting versus bare metal stents.
Dibra A; Ndrepepa G; Mehilli J; Dirschinger J; Pache J; Schühlen H; Schömig A; Kastrati A
Am J Cardiol; 2005 May; 95(10):1238-40. PubMed ID: 15878000
[TBL] [Abstract][Full Text] [Related]
10. Impact of C-reactive protein on in-stent restenosis: a meta-analysis.
Li JJ; Ren Y; Chen KJ; Yeung AC; Xu B; Ruan XM; Yang YJ; Chen JL; Gao RL
Tex Heart Inst J; 2010; 37(1):49-57. PubMed ID: 20200627
[TBL] [Abstract][Full Text] [Related]
11. A randomized, double-blind, placebo-controlled trial of abciximab for prevention of in-stent restenosis in diabetic patients after coronary stenting: results of the ASIAD (Abciximab in Stenting Inhibits restenosis Among Diabetics) Trial.
Chen WH; Kaul U; Leung SK; Lau YK; Tan HC; Leung AW; Lee MK; Li SK; Ng W; Lee PY; Lam KF; Tse HF; Lau CP
J Invasive Cardiol; 2005 Oct; 17(10):534-8. PubMed ID: 16204748
[TBL] [Abstract][Full Text] [Related]
12. Predictive value of C-reactive protein in patients with unstable angina pectoris undergoing coronary artery stent implantation.
Karaca I; Aydin K; Yavuzkir M; Ilkay E; Akbulut M; Isik A; Arslan N
J Int Med Res; 2005; 33(4):389-96. PubMed ID: 16104442
[TBL] [Abstract][Full Text] [Related]
13. Treatment of left anterior descending coronary artery disease with sirolimus-eluting stents.
Sawhney N; Moses JW; Leon MB; Kuntz RE; Popma JJ; Bachinsky W; Bass T; DeMaio S; Fry E; Holmes DR; Teirstein PS
Circulation; 2004 Jul; 110(4):374-9. PubMed ID: 15249503
[TBL] [Abstract][Full Text] [Related]
14. Predictive value of preprocedural fibrinogen concerning coronary stenting.
Otsuka M; Hayashi Y; Ueda H; Imazu M; Kohno N
Atherosclerosis; 2002 Oct; 164(2):371-8. PubMed ID: 12204810
[TBL] [Abstract][Full Text] [Related]
15. Relationship between activated clotting time and ischemic or hemorrhagic complications: analysis of 4 recent randomized clinical trials of percutaneous coronary intervention.
Brener SJ; Moliterno DJ; Lincoff AM; Steinhubl SR; Wolski KE; Topol EJ
Circulation; 2004 Aug; 110(8):994-8. PubMed ID: 15302778
[TBL] [Abstract][Full Text] [Related]
16. Preprocedural C-reactive protein levels and cardiovascular events after coronary stent implantation.
Walter DH; Fichtlscherer S; Sellwig M; Auch-Schwelk W; Schächinger V; Zeiher AM
J Am Coll Cardiol; 2001 Mar; 37(3):839-46. PubMed ID: 11693760
[TBL] [Abstract][Full Text] [Related]
17. Plasma levels of C-reactive protein and interleukin-10 predict late coronary in-stent restenosis 6 months after elective stenting.
Zurakowski A; Wojakowski W; Dzielski T; Milewski K; Gościńska-Bis K; Tendera M; Buszman P
Kardiol Pol; 2009 Jun; 67(6):623-30. PubMed ID: 19618318
[TBL] [Abstract][Full Text] [Related]
18. Abciximab and angiographic restenosis after coronary stent placement. Analysis of the angiographic substudy of ISAR-REACT--a double-blind, placebo-controlled, randomized trial evaluating abciximab in patients undergoing elective percutaneous coronary interventions after pretreatment with a high loading dose of clopidogrel.
Schühlen H; Kastrati A; Mehilli J; Hausleiter J; Dirschinger J; Dotzer F; Bollwein H; Schömig A
Am Heart J; 2006 Jun; 151(6):1248-54. PubMed ID: 16781230
[TBL] [Abstract][Full Text] [Related]
19. Comparison of effects of drug-eluting stents versus bare metal stents on plasma C-reactive protein levels.
Kim JY; Ko YG; Shim CY; Park S; Hwang KC; Choi D; Jang Y; Chung N; Shim WH; Cho SY
Am J Cardiol; 2005 Nov; 96(10):1384-8. PubMed ID: 16275183
[TBL] [Abstract][Full Text] [Related]
20. Randomised comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease (Benestent II).
Serruys PW; van Hout B; Bonnier H; Legrand V; Garcia E; Macaya C; Sousa E; van der Giessen W; Colombo A; Seabra-Gomes R; Kiemeneij F; Ruygrok P; Ormiston J; Emanuelsson H; Fajadet J; Haude M; Klugmann S; Morel MA
Lancet; 1998 Aug; 352(9129):673-81. PubMed ID: 9728982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
